Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000265895 | SCV000339274 | benign | not specified | 2016-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000265895 | SCV000532743 | benign | not specified | 2016-12-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000871123 | SCV001012728 | benign | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002512074 | SCV002821776 | benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | SYNE1: BS1, BS2 |
Prevention |
RCV004535357 | SCV004754724 | benign | SYNE1-related disorder | 2019-06-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |